- Biopsy
- To confirm receptor status and provide tissue for further testing re clinical trial eligibility
- Consider radiotherapy to rib lesion for pain relief (best to do early rather than need to interrupt systemic treatment)
- Dr Marita Morgia’s team to arrange appointment
- Clinical trial
- JAVELIN PARP Medley trial (avelumab plus talazoparib)– Prof Richard Kefford at Macquarie University Hospital
- b. Other options include:
- Keytruda (pembrolizumab) – self-funded
- Another clinical trial
- ARCS- Multi tumour (anetumab ravtansine in mesothelin expressing advanced solid tumours) – Prof Richard Kefford at Macquarie University Hospital
- Xgeva (denosumab) to treat and protect bones (to be discussed)
![Immunotherapy-For-Tripple-Negative-Breast-Cancer-Louise-Decelis-Cancer-Blog](https://louisedecelis.me/wp-content/uploads/2023/07/Immunotherapy-For-Tripple-Negative-Breast-Cancer-Louise-Decelis-Cancer-Blog-500x250.jpg)
3 Aug 18